# FDA Inspection 1152174 - Takeda Pharmaceuticals U.S.A. - September 01, 2021

Source: https://www.keypedia.com/records/fda_inspections/takeda-pharmaceuticals-usa/243add49-3771-4c66-a4c3-4e2af69c2f4f
Source feed: FDA_Inspections

> FDA Inspection 1152174 for Takeda Pharmaceuticals U.S.A. on September 01, 2021. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1152174
- Company Name: Takeda Pharmaceuticals U.S.A.
- Inspection Date: 2021-09-01
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1148841 - 2021-07-28](https://www.keypedia.com/records/fda_inspections/takeda-pharmaceuticals-usa/5896722f-a14f-4e64-aef5-a765c5d3b368)

Company: https://www.keypedia.com/companies/takeda-pharmaceuticals-usa/b8d70251-c1a8-4fce-8388-5fc96dd4c381

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d